Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03852472 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)
A Phase 2 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 2
- Development phase
- 435
- Enrollment target
NCT03852472 is a Phase 2 study that has completed, run by Amgen. The registered enrollment target is 435 participants.
The verdict
NCT03852472, a Phase 2 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 435 participants
- Enrollment target
Study Summary
Phase 2 study of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
Interventions
- OTHER Placebo
- DRUG Avacopan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 435 participants |
| Start Date | 2018-12-21 |
| Est. Completion | 2021-03-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03852472
The ClinicalTrials.gov registry entry for NCT03852472 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 435 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03852472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03852472 about?
NCT03852472 is a clinical study titled "Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)". Phase 2 study of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
What is the current status of trial NCT03852472?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 435 participants. The study started on 2018-12-21. Estimated completion is 2021-03-09.
What interventions are being tested in trial NCT03852472?
The interventions under investigation include: Placebo (OTHER), Avacopan (DRUG).
Who is sponsoring clinical trial NCT03852472?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.